Brought to you by 
Purdue Pharma tenders to buy CoCensys
15 Mar 2000
Executive Summary
Purdue Pharma (drug company focused chiefly on pain management) is making a tender offer of $6.8mm cash for the 5.9mm outstanding shares of CoCensys (biotech developing small-molecule drugs for neurological and psychiatric disorders).
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Purdue Pharma tenders to buy CoCensys
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice